Trials / Sponsors / NeuroPro Therapeutics, Inc.
NeuroPro Therapeutics, Inc.
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared Epilepsy, Alzheimer Disease, Epilepsy Intractable | Phase 1 | 2025-09-29 |
| Recruiting | A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE Epilepsy, Generalized, Epilepsy, Absence | Phase 2 | 2025-03-11 |
| Completed | A Double Blind, Randomized, Cross-over Study Examining the Suppression of the Photoparoxysmal EEG Response Wit Photosensitive Epilepsy, Epilepsy | Phase 1 | 2024-08-21 |
| Completed | Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjec Epilepsy, Alzheimer Disease, Epilepsy Intractable | Phase 1 | 2022-10-20 |